(Date:12/1/2009)...wswire/ -- Reportlinker.com announces that a new m...e: ,, Chromium - Global Market Trends ,,...Global-Market-Trends.html ,, Worldwide demand ...steel, while growth in aerospace and industrial ga...chromium metal. Environmental constraints and rapi...
(Date:12/1/2009)...ewswire/ -- Harvest Technologies Corp. ( www.harve...any sponsored 60-patient clinical trial conducted ...a using the company,s BMAC System to treat patient...(CLI). Sri Ramachandra Medical Center is a Harvard...d in Chennai, India and one of the largest private...
(Date:12/1/2009)...swire-Asia/ -- Shanghai ChemPartner, as the,flagsh...d Contract Research,Organization (CRO), today anno...gy Fast 50 China, ranking 3rd on the list of the f...ward is a testament to ChemPartner,s outstanding,t... The results of the 2009 Deloitte Technology F...
(Date:12/1/2009)...swire/ -- The Burrill Biotech Select Index managed...ober. The Select,s gain of 4.5 percent mirrored wh...kets with the Dow up 6.5 percent and the NASDAQ up...final two trading days of the month despite invest...pping and Dubai,s reported debt woes. ,, Almost...
Breaking Biology Technology:Reportlinker Adds Chromium - Global Market Trends 2Reportlinker Adds Chromium - Global Market Trends 3Reportlinker Adds Chromium - Global Market Trends 4Reportlinker Adds Chromium - Global Market Trends 5Reportlinker Adds Chromium - Global Market Trends 6Reportlinker Adds Chromium - Global Market Trends 7Reportlinker Adds Chromium - Global Market Trends 8Reportlinker Adds Chromium - Global Market Trends 9Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 2Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 3Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 2Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 3Biotech Gets Back on Track in November 2Biotech Gets Back on Track in November 3Biotech Gets Back on Track in November 4...:00 a.m. EST , , WALTHAM, Mass., Jan. 29 Replig...hat the Company President and Chief Executive Offi...nce call and webcast on Thursday, February 5th, 20...al year 2009 financial results and to provide a qu...eing webcast by Thomson/CCBN and can be accessed v...
...n Next Generation Laboratory Instruments , , MENL...er, Inc. and Advanced Instruments, Inc. today join...ade a $1 Million equity investment in Cantimer. T... to collaborate on the development of a new genera...urement, incorporating Cantimer,s proprietary sens...
...CuraGen Corporation (Nasdaq: CRGN ), today report...d calendar year of 2008 and provided milestone and... , During the three month period ended December 31...investments and ended the fourth quarter with $88 ...2008, CuraGen has outstanding $19 million of 4% co...
Other Biology Technology:Repligen Announces Conference Call of Third Quarter Fiscal Year 2009 Results 2Repligen Announces Conference Call of Third Quarter Fiscal Year 2009 Results 3Advanced Instruments Makes Strategic Investment in Cantimer, Inc. 2CuraGen Reports Fourth Quarter 2008 Financial Results; Provides Milestone and Financial Guidance for First Half of 2009 2CuraGen Reports Fourth Quarter 2008 Financial Results; Provides Milestone and Financial Guidance for First Half of 2009 3CuraGen Reports Fourth Quarter 2008 Financial Results; Provides Milestone and Financial Guidance for First Half of 2009 4CuraGen Reports Fourth Quarter 2008 Financial Results; Provides Milestone and Financial Guidance for First Half of 2009 5CuraGen Reports Fourth Quarter 2008 Financial Results; Provides Milestone and Financial Guidance for First Half of 2009 6Mouse Anti-PSD-95, PDZ Domain Monoclonal Antibody, Unconjugated, Clone K28/86.2 from Upstate
... western blots ,• Optically clear plastic c...r staining western blots. The reduced size (60 x 7...e and antibodies resulting in a significant cost s...ilitate pouring of liquid. Optically clear APET pl...
...d and created in order to provide genetic research...tool. We incorporated the suggestions and requirem... Their main requirements were ease- of- use, high ...eneMarker can perform analysis on up to 1,000 lane...
pYES2/CT from Invitrogen
Biology Products: